| Literature DB >> 15489015 |
P Põder1, M Zilmer, J Starkopf, J Kals, A Talonpoika, A Pulges, U Langel, T Kullisaar, S Viirlaid, R Mahlapuu, A Zarkovski, A Arend, U Soomets.
Abstract
Different glutathione analogues have potential to maintain or increase tissue glutathione level and to scavenge the reactive oxygen species. We designed and synthesized a novel non-toxic glutathione analogue, named UPF1, which possessed 60-fold higher hydroxyl radical scavenger efficiency in vitro, compared with glutathione itself, and investigated the effects of UPF1 on a four-vessel occlusion model of rats. The UPF1 was administered via the jugular vein in two separate experiments at two time points: 20 min before global brain ischemia and immediately before reperfusion. In both cases the number of pyramidal cells surviving in the subfield of CA1 at the dorsal hippocampus in the UPF1-treated groups of rats was twice as high as in the vehicle group.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15489015 DOI: 10.1016/j.neulet.2004.07.063
Source DB: PubMed Journal: Neurosci Lett ISSN: 0304-3940 Impact factor: 3.046